| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/12/2002 | WO2001077360A3 Methods for ansamitocin production |
| 09/12/2002 | WO2001077335A3 Listeria monocytogenes genome, polypeptides and uses |
| 09/12/2002 | WO2001036626A9 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 09/12/2002 | WO2001035102A3 Diagnosis and treatment of malignant neoplasms |
| 09/12/2002 | WO2001018175A9 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| 09/12/2002 | WO2001009192A9 Human monoclonal antibodies to prostate specific membrane antigen |
| 09/12/2002 | WO2000077236A3 Methods for enhancing the production of cytokines in cell cultur e |
| 09/12/2002 | WO2000077182A9 Nucleic acid fragment and vector containing halogenase and method for the halogenation of chemical compounds |
| 09/12/2002 | WO2000073801A3 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 09/12/2002 | WO2000069901A3 Proteins with insulin-like activity useful in the treatment of diabetes |
| 09/12/2002 | WO2000067792A9 Monoclonal antibody directed against cells of human renal cell carcinoma |
| 09/12/2002 | WO2000066727A9 Tumour-associated antigen |
| 09/12/2002 | US20020129388 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of atherosclerosis |
| 09/12/2002 | US20020129387 Mammals' milk containing recombinant protein for use in human therapeutics |
| 09/12/2002 | US20020128461 Orphan receptor |
| 09/12/2002 | US20020128459 Physiologically active protein originating in mammals |
| 09/12/2002 | US20020128449 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells |
| 09/12/2002 | US20020128446 Polypeptide for use in the treatment of cell proliferation and differtiation disorders |
| 09/12/2002 | US20020128443 Polynucleotides encoding thrombin receptor homologs |
| 09/12/2002 | US20020128442 Human proteins STAM2a and STAM2b, and cDNAs encoding these molecules |
| 09/12/2002 | US20020128437 Polypeptide for use in the detection of bactericides and prevention, detect and treatment of infections |
| 09/12/2002 | US20020128436 Therapeutic composition for use in the treatment of autoimune and rheumatic diseases |
| 09/12/2002 | US20020128435 Polypeptide for use in treatment of bone and cell proliferation disorders |
| 09/12/2002 | US20020128192 Insecticides against coleopteran insects including red flour beetle larvae and Japanese beetle larvae (Popillia japonica); transgenic plants having genes encoding crystal protein or peptide; immunodetection kits |
| 09/12/2002 | US20020127691 Enzymatic protein for treating inflammation, thrombosis andrestenosis |
| 09/12/2002 | US20020127689 Novel human galectins |
| 09/12/2002 | US20020127687 Genome DNA of bacterial symbiont of aphids |
| 09/12/2002 | US20020127684 Novel cark protein and nucleic acid molecules and uses therefor |
| 09/12/2002 | US20020127676 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 09/12/2002 | US20020127668 Polypeptide for use in the diagnosis and treatment of cancer, nervous system and vessicular transport disorders |
| 09/12/2002 | US20020127654 Genetically engineered cell for use as tool in genetic engineering |
| 09/12/2002 | US20020127653 Hematopoietic signaling factor |
| 09/12/2002 | US20020127647 ATP-binding cassette transporter-like molecules and uses thereof |
| 09/12/2002 | US20020127645 Secretory immunoglobulin produced by single cells and methods for making and using same |
| 09/12/2002 | US20020127644 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/12/2002 | US20020127643 Nucleotide sequences coding membrane proteins for use in human therapeutics and diagnostics |
| 09/12/2002 | US20020127638 Human metabotropic glutamate receptor 7 subtypes |
| 09/12/2002 | US20020127621 KUZ, a novel family of metalloproteases |
| 09/12/2002 | US20020127612 Cell proliferation polypeptide for use in the diagnosis and treatment of tumors |
| 09/12/2002 | US20020127611 Detecting preferential water treatment polymer; generate antibody, incubate with water sample, monitor for the presence of preferential polymer |
| 09/12/2002 | US20020127601 Detecting modulators of g-protein coupled receptor activity; obtain cell containing g-protein coupled receptor pathway, incubate with modulator, determine quantative and qualitative effect of modulator on receptor |
| 09/12/2002 | US20020127596 murF2 |
| 09/12/2002 | US20020127595 Endostatin; for use as a contraceptive and in cancer treatment |
| 09/12/2002 | US20020127584 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/12/2002 | US20020127576 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of cancer, nervous system and blood disorders |
| 09/12/2002 | US20020127571 Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations |
| 09/12/2002 | US20020127550 Nucleic acid sequences and methods for identifying compounds that affect rna/rna binding protein interactions and mrna functionality |
| 09/12/2002 | US20020127288 Method for producing ultrapure vegetable protein materials |
| 09/12/2002 | US20020127247 Modified clostridial neurotoxins with altered biological persistence |
| 09/12/2002 | US20020127240 Leptospiral rare outer membrane proteins |
| 09/12/2002 | US20020127231 Extracellular domains of a heterodimeric protein operatively linked to immunoglobulin heavy and light chain polypeptides |
| 09/12/2002 | US20020127227 Antagonist monoclonal antibodies (mAb) that bind to the RHAMM (receptor for hyaluronic acid mediated motility) receptor; useful for preventing proliferative disease states in a mammal |
| 09/12/2002 | US20020127221 Urocortin proteins and uses thereof |
| 09/12/2002 | US20020127219 A polypeptide selected from lysosomal enzymes and lysosomal enzyme activators, consist of at least one introduced glycosylation site as compared to a corresponding parent enzyme or activator |
| 09/12/2002 | US20020127217 A polynucleotides which identify and encode Phosphatidylinositol 4,5-bisphosphate 5-phosphatase (polypeptide) |
| 09/12/2002 | DE10109855A1 Polypeptide eines p53-Protein-spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung Polypeptide of a p53 protein specific murine alpha / beta T-cell receptor nucleic acids encoding these, and their use |
| 09/12/2002 | DE10109854A1 Polypeptide eines hdm2-Protein spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung Polypeptides of hdm2 protein specific murine alpha / beta T-cell receptor nucleic acids encoding these, and their use |
| 09/12/2002 | DE10109813A1 Tumor-Peptidantigen aus humanem mdm2 Proto-Onkogen Tumor antigen peptide from human MDM2 proto-oncogene |
| 09/12/2002 | CA2445018A1 Tumour peptide antigen produced from human mdm2 proto-oncogene |
| 09/12/2002 | CA2445013A1 Polypeptides of an hdm2 protein-specific murine alpha/beta t-cell receptor, nucleic acids encoding these and their use |
| 09/12/2002 | CA2445004A1 Polypeptides of a p53 protein-specific murine alpha/beta t-cell receptor, nucleic acids encoding these and their use |
| 09/12/2002 | CA2441476A1 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 09/12/2002 | CA2440809A1 Methods for treating genetically-defined proliferative disorders with hsp90 inhibitors |
| 09/12/2002 | CA2439941A1 Secreted proteins |
| 09/12/2002 | CA2439929A1 Modified protamine with reduced immunogenicity |
| 09/12/2002 | CA2439682A1 Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity |
| 09/12/2002 | CA2439636A1 Mouse cytokine receptor |
| 09/12/2002 | CA2439628A1 Vaccine |
| 09/12/2002 | CA2439594A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | CA2439042A1 Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
| 09/12/2002 | CA2438375A1 Plant cell having animal-type sugar chain adding function |
| 09/12/2002 | CA2436815A1 Dna sequence from kluyveromyces marxianus comprising regulatory regions for expressing proteins |
| 09/12/2002 | CA2432280A1 Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor |
| 09/12/2002 | CA2431500A1 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
| 09/11/2002 | EP1239047A2 Method for producing proteins |
| 09/11/2002 | EP1239043A2 Fusion proteins comprising tumour necrosis factor receptor |
| 09/11/2002 | EP1239037A1 PROCESS FOR PRODUCING KiSS-1 PEPTIDE |
| 09/11/2002 | EP1239036A1 Polynucleotides, polypeptides, remedies for cancer and vaccines |
| 09/11/2002 | EP1238986A2 Use of Vascular endothelial cell growth factor antagonists |
| 09/11/2002 | EP1238985A1 Human type complementarity determining region transplantation antibody against ganglioside gd3 and derivatives of antibody against ganglioside gd3 |
| 09/11/2002 | EP1238282A2 Methods of diagnosis and treatment by binding p75/airm1 |
| 09/11/2002 | EP1238281A2 Cancer associated antigens and uses therefor |
| 09/11/2002 | EP1238085A2 Bacillus thuringiensis toxin active against formicidae (ant) |
| 09/11/2002 | EP1238084A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/11/2002 | EP1238080A2 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 09/11/2002 | EP1238075A2 Chordin-like molecules and uses thereof |
| 09/11/2002 | EP1238066A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 09/11/2002 | EP1238064A2 Srik a novel cell cycle protein associated with rip3 |
| 09/11/2002 | EP1238063A2 Tankyrase h, compositions involved in the cell cycle and methods of use |
| 09/11/2002 | EP1237930A2 Chimeric peptides (short b-cell epitope joined to a t-cell epitope) and their use for immunization |
| 09/11/2002 | EP1237927A2 Antibodies and a method for producing same, the use thereof and immunisation cocktails, immunoassay-sets and peptides |
| 09/11/2002 | EP1237916A2 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 09/11/2002 | EP1237915A2 Polynucleotid encoding the rg1 polypeptide |
| 09/11/2002 | EP1237901A1 28 human secreted proteins |
| 09/11/2002 | EP0832098B1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding |
| 09/11/2002 | EP0808169A4 Programmed cell death genes and proteins |
| 09/11/2002 | CN1369015A Recombinant anti-CD 40 antibody and uses thereof |
| 09/11/2002 | CN1369014A Production of proteins |
| 09/11/2002 | CN1369009A Modified chimeric polyeptides with improved pharmacokinetic properties |
| 09/11/2002 | CN1368888A Anti-human mitochondrial a denylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disaese |